BASFY

Q: What is the price of BASF SE ADR (BASFY) today?

The current price of BASF SE ADR (BASFY) is $ 15.90, representing a 36.39% gain over the past year. The stock began the year trading around $ 12.98 and is currently priced at $ 15.90. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does BASF SE ADR (BASFY) pay dividends?

BASF SE ADR (BASFY) did not pay dividends over the past year.

Q: Is BASF SE ADR (BASFY) a good investment?

BASF SE ADR (BASFY) is currently trading at $ 15.90 with a P/E ratio of 30.26%. This represents a 1,402% premium compared to its historical average P/E. Over the past year, the stock has gained 36.39 and paid $ 0.00 in dividends, resulting in a dividend yield of 4.07%. The total shareholder return over the same period was 36.39%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

BASF SE ADR

Price

$ 15.90

return (12m)

36.39%

p/e

30.26

p/bv

1.37

DIVIDEND YIELD

4.07%

BASFY price

BASFY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BASFY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.76%

3 months

20.12%

1 year

36.39%

2 years

35.63%

5 years

5.60%

10 years

45.46%

Fundamentals BASFY

review the fundamentals of BASF SE ADR shares

P/E

30.26

Sector: 8.14 Industry: 8.14

P/S (PSR)

0.79

Sector: 2.43 Industry: 2.43

P/BV

1.37

Sector: 2.13 Industry: 2.13

DIVIDEND YIELD (DY)

4.07%

Sector: 0.66% Industry: 0.66%

ROA

2.04%

Sector: 0.39% Industry: 0.39%

ROE

4.53%

Sector: 4.44% Industry: 4.44%

ROIC

2.28%

Sector: -75.58% Industry: -75.58%

NET MARGIN

2.59%

Sector: 3.03% Industry: 3.03%

GROSS MARGIN

24.79%

Sector: 32.15% Industry: 32.15%

OPERATING MARGIN

4.79%

Sector: 4.82% Industry: 4.82%

EV/EBITDA

6.25

Sector: 3.38 Industry: 3.38

EV/EBIT

13.62

Sector: 1.47 Industry: 1.47

PRICE-TO-ASSETS

0.62

Sector: 1.04 Industry: 1.04

BVPS

11.30

Sector: 9.55 Industry: 9.55

EPS

0.51

Sector: 0.71 Industry: 0.71

EQUITY-TO-ASSETS RATIO

0.45

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.55

Sector: 0.51 Industry: 0.51

CAGR REVENUE 5 YEARS

-73.63%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-78.88%

Sector: - Industry: -

FAIR VALUE OF BASF SE ADR ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 15.90

Fair Value

$ 0.00

Upside/Downside Return potential.

-28.38%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BASFY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	28.75	8.00	27.83%	0.31%	$ 1.74 T	30.08%
INTR	15.61	1.95	12.49%	1.34%	$ 3.71 B	15.62%
PBR	6.56	1.73	26.37%	5.83%	$ 131.78 B	22.13%
VALE	32.27	2.21	6.85%	5.70%	$ 75.90 B	6.12%
PLTR	215.03	46.67	21.70%	0.00%	$ 349.43 B	36.31%
SHEL	14.39	1.46	10.17%	3.29%	$ 256.67 B	6.68%
BDORY	11.32	0.79	6.98%	2.34%	$ 28.03 B	9.30%
MAIN	10.00	1.65	16.48%	7.24%	$ 4.93 B	83.37%
ENB	21.35	2.43	11.38%	5.17%	$ 114.82 B	11.49%
NSRGY	11.07	6.25	56.41%	3.37%	$ 259.11 B	10.91%
PBR-A	5.96	1.57	26.37%	5.79%	$ 119.79 B	22.13%
ITUB	13.51	2.78	20.61%	2.61%	$ 109.72 B	27.17%
UNH	24.40	2.89	11.85%	2.72%	$ 294.11 B	2.69%
BBSEY	8.41	7.22	85.85%	11.34%	$ 13.74 B	100.00%
SAN	12.50	1.53	12.24%	1.64%	$ 202.00 B	23.74%
TTE	14.71	1.64	11.17%	6.45%	$ 193.12 B	7.20%
RACE	36.10	0.00	0.00%	0.84%	$ 65.99 B	22.35%
TD	11.29	1.94	17.19%	2.86%	$ 176.99 B	34.54%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BASFY Historical Dividends

current DY: 4.07%

5-year average DY: 7.64%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/05/2026	05/18/2026	0,45830000
Dividends	05/06/2025	05/19/2025	0,63010000
Dividends	04/29/2024	05/10/2024	0,92300000
Dividends	05/02/2023	05/08/2023	0,89900000
Dividends	05/03/2022	05/16/2022	0,93300000
Dividends	05/03/2021	05/14/2021	0,98000000
Dividends	06/22/2020	07/06/2020	0,93200000
Dividends	05/07/2019	05/20/2019	0,90200000
Dividends	05/08/2018	05/21/2018	0,94400000
Dividends	05/17/2017	05/24/2017	0,79875000
Dividends	04/29/2016	05/09/2016	0,83975000
Dividends	04/30/2015	05/11/2015	0,74050000
Dividends	05/02/2014	05/12/2014	0,92950000
Dividends	04/26/2013	05/06/2013	0,84275000
Dividends	04/27/2012	05/04/2012	0,82450000
Dividends	05/06/2011	05/19/2011	0,76475000
Dividends	04/29/2010	05/10/2010	0,57425000
Dividends	04/30/2009	05/14/2009	0,63325000
Dividends	04/24/2008	05/05/2008	0,76137500
Dividends	04/26/2007	05/07/2007	0,49875000
Dividends	05/04/2006	05/15/2006	0,29787500
Dividends	04/28/2005	05/09/2005	0,28400000
Dividends	04/29/2004	05/10/2004	0,21525000
Dividends	05/06/2003	05/19/2003	0,19275000
Dividends	04/30/2002	05/13/2002	0,14225000
Dividends	04/26/2001	05/03/2001	0,23325000

ABOUT BASF SE ADR

BASF SE ADR

Average Investor10 user rating

1.0 (17 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Solventum Corporation operates in the healthcare sector within the medical technology and healthcare solutions industry. The company was created through the spin-off of 3M’s healthcare business, focusing on medical technologies, clinical solutions and healthcare management systems.

Solventum develops products and technologies designed to support hospitals, healthcare professionals and clinical laboratories.

Its main areas of activity include:

• Medical devices and healthcare products used in hospital and clinical environments.
• Dental and oral care technologies for professional dental practices.
• Infection prevention and sterilization solutions used in healthcare facilities.
• Healthcare data and analytics platforms supporting clinical documentation and hospital management.

The company serves healthcare providers such as hospitals, clinics, laboratories and dental practices, offering products and software solutions aimed at improving clinical efficiency and patient safety.

Solventum maintains operations across North America, Europe and Asia, supported by research centers, manufacturing facilities and global distribution networks.

Industry dynamics affecting the company include regulatory requirements for medical technologies, digital transformation in healthcare, advances in medical devices and increasing demand for healthcare efficiency and data-driven clinical systems.

Shares of Solventum Corporation trade on Nasdaq under the ticker SOLV.

History and Development

Solventum Corporation was established in 2024 in the United States following the spin-off of 3M’s healthcare division, which had historically developed a wide range of medical technologies and clinical solutions.

The separation was announced in 2022, with the objective of creating an independent company dedicated exclusively to healthcare innovation and medical technologies.

Following the spin-off, Solventum focused on building its independent operational structure while maintaining the product portfolio and technologies previously developed within 3M’s healthcare business.

In 2024, the company became publicly listed on Nasdaq, marking the beginning of its operations as a standalone publicly traded healthcare technology company.

Since its creation, Solventum has continued investing in research, automation and digital healthcare technologies, focusing on medical devices, clinical data systems and healthcare solutions designed to improve operational efficiency in healthcare institutions.

Additional Information

BASF SE ADR (United States) is listed on the Nasdaq and has a market capitalization of $55.15 Billions, with shareholders equity totaling $40.21 Billions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, BASF SE ADR reported $70.25 Billions in revenue, generating net income of $1.82 Billion.

Key financial metrics include a P/E ratio of 30.26, a price-to-book (P/B) ratio of 1.37, and a trailing twelve-month dividend yield of 4.07%.

The company trades under the ticker BASFY.

Market cap

$ 55.15 Billions

Net worth

$ 40.21 Billions

$ 40,207,260,000.00

Assets

$ 89.20 Billions

$ 89,196,720,000.00

Total Shares Outstanding

3.56 Billions

3,558,000,000

Average Daily Trading Volume

$ 182.43 Thousand

$ 182,434.56

Sector

Others

Industry

Others

BASFY

revenue by Business Segment BASF SE ADR

Revenue by Region BASF SE ADR

BASFY revenue and profits

Financial Results BASFY

DRAG THE FRAME TO SEE MORE DATA

BASFY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 66.38 97,37% (12M)

P/E

0.01

2.28%

ROE

8.97%

P/BV

0.00

ALIZY - Allianz SE ADR

$ 45.59 15,30% (12M)

P/E

1.32

3.72%

ROE

67.54%

P/BV

0.89

CRERF - Carrefour SA

$ 19.40 41,66% (12M)

P/E

2.35

6.59%

ROE

11.14%

P/BV

0.26

UNH - UnitedHealth Group Incorporated

$ 354.92 --12,83% (12M)

P/E

24.40

2.72%

ROE

11.85%

P/BV

2.89

STLA - Stellantis NV

$ 8.06 --7,48% (12M)

P/E

-1.23

8.29%

ROE

-32.04%

P/BV

0.39

COR - Cencora Inc.

$ 308.19 8,57% (12M)

P/E

39.10

0.70%

ROE

77.54%

P/BV

30.32

BLSH - Bullish

$ 39.95 --42,77% (12M)

P/E

-8.59

0.00%

ROE

-23.69%

P/BV

2.03

SHEL - Shell PLC ADR

$ 89.11 40,73% (12M)

P/E

14.39

3.29%

ROE

10.17%

P/BV

1.46